GRAIL, Inc. (GRAL)
140.30
+6.54
(+4.89%)
USD |
NASDAQ |
Nov 03, 15:27
GRAIL Market Cap : 6.267B for Nov. 3, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 02, 2026 | 5.975B |
| October 30, 2026 | 6.406B |
| October 29, 2026 | 7.098B |
| October 28, 2026 | 7.052B |
| October 27, 2026 | 6.727B |
| October 26, 2026 | 6.249B |
| October 23, 2026 | 5.921B |
| October 22, 2026 | 5.675B |
| October 21, 2026 | 5.923B |
| October 20, 2026 | 5.569B |
| October 19, 2026 | 5.468B |
| October 16, 2026 | 5.262B |
| October 15, 2026 | 6.050B |
| October 14, 2026 | 6.240B |
| October 13, 2026 | 6.269B |
| October 12, 2026 | 6.136B |
| October 09, 2026 | 6.279B |
| October 08, 2026 | 5.923B |
| October 07, 2026 | 5.936B |
| October 06, 2026 | 6.132B |
| October 05, 2026 | 6.882B |
| October 02, 2026 | 6.399B |
| October 01, 2026 | 5.921B |
| September 30, 2026 | 6.259B |
| September 29, 2026 | 6.100B |
| Date | Value |
|---|---|
| September 28, 2026 | 5.924B |
| September 25, 2026 | 5.668B |
| September 24, 2026 | 5.593B |
| September 23, 2026 | 4.847B |
| September 22, 2026 | 4.847B |
| September 21, 2026 | 4.823B |
| September 18, 2026 | 3.608B |
| September 17, 2026 | 3.571B |
| September 16, 2026 | 3.355B |
| September 15, 2026 | 3.390B |
| September 14, 2026 | 3.374B |
| September 11, 2026 | 3.405B |
| September 10, 2026 | 3.464B |
| September 09, 2026 | 3.461B |
| September 08, 2026 | 3.533B |
| September 04, 2026 | 3.588B |
| September 03, 2026 | 3.601B |
| September 02, 2026 | 3.598B |
| September 01, 2026 | 3.564B |
| August 31, 2026 | 3.545B |
| August 28, 2026 | 3.573B |
| August 27, 2026 | 3.685B |
| August 26, 2026 | 3.555B |
| August 25, 2026 | 3.687B |
| August 24, 2026 | 3.421B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 90.38B |
| Twist Bioscience Corp. | 8.729B |
| Prime Medicine, Inc. | 810.61M |
| Kailera Therapeutics, Inc. | 1.626B |
| Arrowhead Pharmaceuticals, Inc. | 8.430B |
Market Cap Related Metrics
| PS Ratio | 34.09 |
| Price to Book Value | 2.465 |
| Price | 140.30 |
| Earnings Yield | -6.95% |